Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?
Kura K, Stolk WA, Basáñez MG, Collyer BS, de Vlas SJ, Diggle PJ, Gass K, Graham M, Hollingsworth TD, King JD, Krentel A, Anderson RM, Coffeng LE. Kura K, et al. Among authors: krentel a. Clin Infect Dis. 2024 Apr 25;78(Supplement_2):S93-S100. doi: 10.1093/cid/ciae021. Clin Infect Dis. 2024. PMID: 38662701 Free PMC article.
Persons 'never treated' in mass drug administration for lymphatic filariasis: identifying programmatic and research needs from a series of research review meetings 2020-2021.
Brady MA, Toubali E, Baker M, Long E, Worrell C, Ramaiah K, Graves P, Hollingsworth TD, Kelly-Hope L, Stukel D, Tripathi B, Means AR, Matendechero SH, Krentel A. Brady MA, et al. Among authors: krentel a. Int Health. 2023 Oct 17:ihad091. doi: 10.1093/inthealth/ihad091. Online ahead of print. Int Health. 2023. PMID: 37846645
Assessing factors influencing communities' acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana.
Niles RA, Thickstun CR, Cox H, Dilliott D, Burgert-Brucker CR, Harding-Esch EM, Clementson N, Sampson A, Alexandre JS, Morice Trejos AC, Scholte RGC, Krentel A. Niles RA, et al. Among authors: krentel a. PLoS Negl Trop Dis. 2021 Sep 20;15(9):e0009596. doi: 10.1371/journal.pntd.0009596. eCollection 2021 Sep. PLoS Negl Trop Dis. 2021. PMID: 34543269 Free PMC article.
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.
Krentel A, Basker N, Beau de Rochars M, Bogus J, Dilliott D, Direny AN, Dubray C, Fischer PU, Ga AL, Goss CW, Hardy M, Howard C, Jambulingam P, King CL, Laman M, Lemoine JF, Mallya S, Robinson LJ, Samuela J, Schechtman KB, Steer AC, Supali T, Tavul L, Weil GJ. Krentel A, et al. PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009002. doi: 10.1371/journal.pntd.0009002. eCollection 2021 Mar. PLoS Negl Trop Dis. 2021. PMID: 33657090 Free PMC article. Clinical Trial.
47 results